Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 221-227 , June 2002

Type of diabetes and waist–hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients

  • Hapizah M. Nawawi

      Affiliations

    • Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Jalan Yaacob Latif, Cheras, 56000 Kuala Lumpur, Malaysia
    • Corresponding Author InformationCorresponding author. Tel.: +60-3-9170-2276; fax: +60-3-9173-8255
    • ,
  • Musilawati Muhajir

      Affiliations

    • Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Jalan Yaacob Latif, Cheras, 56000 Kuala Lumpur, Malaysia
    • ,
  • Yeo Chee Kian

      Affiliations

    • Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Jalan Yaacob Latif, Cheras, 56000 Kuala Lumpur, Malaysia
    • ,
  • Wan Nazaimoon Wan Mohamud

      Affiliations

    • Institute of Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia
    • ,
  • Khalid Yusoff

      Affiliations

    • Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Jalan Yaacob Latif, Cheras, 56000 Kuala Lumpur, Malaysia
    • ,
  • B.A.K. Khalid

      Affiliations

    • Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Jalan Yaacob Latif, Cheras, 56000 Kuala Lumpur, Malaysia

,Accepted 7 January 2002.

References 

  1. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein (a) and the risk for myocardial infarction. Atherosclerosis. 1981;38:51–61
  2. Armstrong VW, Cremer P, Eberle E, et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis. 1986;62:249–257
  3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) as a risk factor for myocardial infarction. J. Am. Med. Assoc. 1986;256:2540–2544
  4. Schaefer EJ, Lamon-Fava S, Jenner JL, et al.  Lipoprotein (a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. J. Am. Med. Assoc. 1994;271:1003–9991
  5. Bolibar I, Thompson SG, von Eckardstein A, Sanskamp M, Assman G. Dose–response relationship of serum lipid measurements with the extent of coronary stenosis. Arterioscler. Thromb. Vasc. Biol. 1995;15:1035–1042
  6. Bostom AG, Gagnon DR, Cupples LA, et al.  A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study. Circulation. 1994;90:1688–1695
  7. Kannel W, McGee DL. Diabetes and cardiovascular diseases: the Framingham study. J. Am. Med. Assoc. 1979;241:2035–2038
  8. Heesen BJ, Wolfenbuttel BH, Leurs PB, et al.  Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes. Eur. J. Clin. Invest. 1993;23:580–584
  9. James RW, Boemi M, Sirolla C, Amadio L, Fumelli P, Pometta D. Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia. 1994;38:711–714
  10. Haffner SM. Lipoprotein(a) and diabetes. Diabetes Care. 1993;16:835–840
  11. Jenkins AJ, Steele JS, Janus ED, Best JD. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes. 1991;40:787–790
  12. Murakami K, Ishibashi S, Yoshida Y, Yamada N, Akanuma Y. Lipoprotein(a) as a coronary risk factor in Japanese patients with type 2 (non-insulin-dependent) diabetes mellitus- relation with apolipoprotein (a) phenotypes. Diabetologia. 1998;41:1397–1399
  13. Hirata K, Saku K, Jimi S, Kikuchi S, Hamaguchi H, Arakawa K. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients. Diabetologia. 1995;38:1434–1442
  14. Hiraga T, Kobayashi T, Okubo M, et al.  Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care. 1995;18(2):241–244
  15. Ruiz J, Thillet J, Huby T, et al.  Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes. Diabetologia. 1994;37:585–591
  16. Csaszar A, Dieplinger H, Sandholzer C, et al.  Plasma concentrations of lipoprotein (a) and phenotypes in diabetes mellitus. Diabetologia. 1993;36:47–51
  17. Nielsen FS, Voldsgaard AI, Gall M-A, et al.  Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia. 1993;36:438–444
  18. Kronenberg F, Auinger M, Trenkwalder E, Irsigler K, Dieplinger H. Is apolipoprotein (a) a susceptibility gene for type 1 diabetes mellitus and related to long-term survival. Diabetologia. 1999;42:1021–1027
  19. Salzer B, Stavljeniec A, Jurgens G, Dumic M, Radica A. Polymorphisms of apolipoprotein E, lipoprotein(a) and other lipoproteins in children in type 1 diabetes. Clin. Chem. 1993;39:1427–1432
  20. Klausen IC, Berg Schmidt E, Lervang HH, Gerdes LU, Ditzel JM, Faergeman O. Normal lipoprotein (a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 1992;22:538–541
  21. Expert Committee Report on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  22. Laakso M, Pyorala K. Age of onset and type of diabetes. Diabetes Care. 1985;8:114–117
  23. WHO Study Group on Diabetes mellitus, World Health Organisation Tech. Rep. Ser. 727, Geneva (1985).
  24. Dowse GK, Zimmet PZ, Gareeboo H, et al.  Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care. 1991;14:271–282
  25. Zanchetti A, Chalmers JP, Arakawa K, et al.  The guidelines on the management of mild hypertension- memorandum from a WHO/ISH meeting. Blood Press. 1993;2(2):86–100
  26. Friedwald KT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–501

PII: S0168-8227(02)00009-8

Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 221-227 , June 2002

Article Tools

* Image Usage & Resolution